e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Tuberculosis: from basic science to patient care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The Glutoxim influence on minimum inhibitory concentration of isoniazid-resistant strains of Mycobacterium tuberculosis
N. Solovieva (St. Petersburg, Russian Federation), O. Kulikova (St. Petersburg, Russian Federation), Z. Rakisheva (Astana, Kazakhstan), G. Balasaniantc (St. Petersburg, Russian Federation)
Source:
International Congress 2019 – Tuberculosis: from basic science to patient care
Session:
Tuberculosis: from basic science to patient care
Session type:
Thematic Poster
Number:
4600
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Solovieva (St. Petersburg, Russian Federation), O. Kulikova (St. Petersburg, Russian Federation), Z. Rakisheva (Astana, Kazakhstan), G. Balasaniantc (St. Petersburg, Russian Federation). The Glutoxim influence on minimum inhibitory concentration of isoniazid-resistant strains of Mycobacterium tuberculosis. 4600
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains
Source: Eur Respir J 2015; 45: 285-287
Year: 2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains
Source: Eur Respir J 2015; 45: 287-289
Year: 2015
MIC distributions of 35 antibiotics for 54 clinical isolates of Mycobacterium lentiflavum
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
Susceptibility of
Mycobacterium tuberculosis
strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Mycobacterium abscessus activates cross-resistance following antibiotic exposure
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi)
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Bedaquiline as a potential agent in the treatment of
Mycobacterium abscessus
infections
Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017
Year: 2017
In vitro
activity of quinolones and macrolides against
Mycobacterium avium
complex:a comparison of isolate susceptibility in two general hospitals and one tuberculosis sanatorium located in the same area of Japan
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003
In vitro susceptibility of mycobacterium bovis against moxifloxacin
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Amikacin exposure and susceptibility of macrolide-resistant
Mycobacterium abscessus
Source: ERJ Open Res, 5 (2) 00154-2018; 10.1183/23120541.00154-2018
Year: 2019
Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections
Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016
Year: 2017
Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis
Source: Eur Respir J 2015; 46: 444-455
Year: 2015
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Detection of Mycobacterium tuberculosis in children during complex antimycobacterial therapy
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009
In vitro susceptibility of M. avium against protionamide
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Minimal inhibitory concentrations (MIC) of first line drugs in multidrug resistant strains of M. tuberculosis (MDR-TB)
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept